Home
/ Verseon
/ Competitors

Verseon Competitors and Similar CompaniesClear all

Walvax Biotechnology's competitors and similar companies include SIGA Technologies and Biora Therapeutics.

	Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.	SIGA Technologies SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases.	Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services.
Founding Date	Founding Date 2001	Founding Date 1995	Founding Date 2010
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development
Locations	Locations Kunming, CN HQ	Locations New York, US HQ Corvallis, US	Locations San Diego, US HQ San Diego, US
Employees	Employees 2,388	Employees 4515% increase	Employees 5456% decrease
Valuation ($)	Valuation ($) 3.3 b	Valuation ($) 507.4 m	Valuation ($) 16.4 m
Financial
Revenue (est.)	Revenue (est.) ¥2.4b (FY, 2025)	Revenue (est.) $94.6m (FY, 2025)	Revenue (est.) $4k (FY, 2023)
Cost of goods	Cost of goods ¥615.2m (FY, 2025)	Cost of goods $29.7m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ¥1.8b (FY, 2025)	Gross profit $64.9m (FY, 2025)	Gross profit N/A
Net income	Net income ¥125.2m (FY, 2025)	Net income $23.3m (FY, 2025)	Net income ($124.1m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 72.8m	Total funding raised N/A	Total funding raised $ 138.5m